Morin Prevents Non-Alcoholic Hepatic Steatosis in Obese Rats by Targeting the Peroxisome Proliferator-Activated Receptor Alpha (PPARα)

Overview

Journal Life (Basel)

Specialty Biology

Date 2024 Aug 29

PMID 39202687

Authors

Laila Naif Al-Harbi

Affiliations

Soon will be listed here.

Abstract

Background: Obesity has become a widespread issue globally. Morin, a flavonoid with traditional use in managing hyperglycemia and hyperlipidemia, has demonstrated antioxidant and anti-inflammatory properties in experimental studies. This research aims to explore the anti-obesity potential of morin in rats subjected to a high-fat diet (HFD) and investigate whether its effects are mediated through PPARα regulation.

Methods: Young adult male Wistar albino rats were divided into four groups ( = 8/group): normal, morin (50 mg/kg/BWT, oral), HFD, and HFD + morin (50 mg/kg/BWT, oral). Treatments were administered daily for 17 consecutive weeks.

Results: Morin mitigated the elevation in glucose levels and decreased fasting glucose and insulin levels, along with the HOMA-IR index, in HFD-fed rats. Furthermore, morin reduced calorie intake, final body weights, and the masses of subcutaneous, epididymal, peritoneal, and mesenteric fat in these rats. It also attenuated the rise in systolic blood pressure in HFD-fed rats and decreased serum levels of triglycerides, cholesterol, free fatty acids, LDL-c, and leptin, while increasing levels of HDL-c and adiponectin in both normal and HFD-fed rats. Moreover, morin restored normal liver structure and reduced fat vacuole accumulation in HFD-fed rats. Notably, it upregulated mRNA levels of PPARα in the livers and white adipose tissue of both normal and HFD-fed rats.

Conclusions: These findings suggest the potential use of morin to enhance fatty acid oxidation in white adipose tissue and mitigate obesity, warranting further clinical investigation into its therapeutic applications.

References

Samuel V, Shulman G . Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab. 2017; 27(1):22-41. PMC: 5762395. DOI: 10.1016/j.cmet.2017.08.002. View

Lopez-Tenorio I, Dominguez-Lopez A, Miliar-Garcia A, Escalona-Cardoso G, Real-Sandoval S, Gomez-Alcala A . Modulation of the mRNA of the Nlrp3 inflammasome by Morin and PUFAs in an obesity model induced by a high-fat diet. Food Res Int. 2020; 137:109706. DOI: 10.1016/j.foodres.2020.109706. View

Skurk T, Alberti-Huber C, Herder C, Hauner H . Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab. 2006; 92(3):1023-33. DOI: 10.1210/jc.2006-1055. View

Paoli P, Cirri P, Caselli A, Ranaldi F, Bruschi G, Santi A . The insulin-mimetic effect of Morin: a promising molecule in diabetes treatment. Biochim Biophys Acta. 2013; 1830(4):3102-11. DOI: 10.1016/j.bbagen.2013.01.017. View

Araki M, Nakagawa Y, Oishi A, Han S, Wang Y, Kumagai K . The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice. Int J Mol Sci. 2018; 19(7). PMC: 6073532. DOI: 10.3390/ijms19072148. View

Yang S, Choi J, Chae S, Kim W, Park S, Rhee E . Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats. PLoS One. 2011; 6(2):e17057. PMC: 3044155. DOI: 10.1371/journal.pone.0017057. View

Khanna D, Khanna S, Khanna P, Kahar P, Patel B . Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus. 2022; 14(2):e22711. PMC: 8967417. DOI: 10.7759/cureus.22711. View

V P V, Rajamanikandan S, Perumal M . Morin inhibits the activity of pancreatic lipase and adipogenesis. Eur J Pharmacol. 2024; 977:176705. DOI: 10.1016/j.ejphar.2024.176705. View

Buzzetti E, Pinzani M, Tsochatzis E . The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016; 65(8):1038-48. DOI: 10.1016/j.metabol.2015.12.012. View

10.

Dias M, Dos Reis S, da Conceicao L, de Oliveira Sediyama C, Silveira Pereira S, Oliveira L . Diet-induced obesity in animal models: points to consider and influence on metabolic markers. Diabetol Metab Syndr. 2021; 13(1):32. PMC: 7976703. DOI: 10.1186/s13098-021-00647-2. View

11.

Krishna K, Stefanovic-Racic M, Dedousis N, Sipula I, ODoherty R . Similar degrees of obesity induced by diet or aging cause strikingly different immunologic and metabolic outcomes. Physiol Rep. 2016; 4(6). PMC: 4814885. DOI: 10.14814/phy2.12708. View

12.

Vanitha P, Uma C, Suganya N, Bhakkiyalakshmi E, Suriyanarayanan S, Gunasekaran P . Modulatory effects of morin on hyperglycemia by attenuating the hepatic key enzymes of carbohydrate metabolism and β-cell function in streptozotocin-induced diabetic rats. Environ Toxicol Pharmacol. 2014; 37(1):326-35. DOI: 10.1016/j.etap.2013.11.017. View

13.

Hruby A, Hu F . The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics. 2014; 33(7):673-89. PMC: 4859313. DOI: 10.1007/s40273-014-0243-x. View

14.

Shariq O, McKenzie T . Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020; 9(1):80-93. PMC: 7082272. DOI: 10.21037/gs.2019.12.03. View

15.

Buechler C, Wanninger J, Neumeier M . Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol. 2011; 17(23):2801-11. PMC: 3120939. DOI: 10.3748/wjg.v17.i23.2801. View

16.

Vernarelli J, Mitchell D, Rolls B, Hartman T . Methods for calculating dietary energy density in a nationally representative sample. Procedia Food Sci. 2014; 2:68-74. PMC: 3889114. DOI: 10.1016/j.profoo.2013.04.011. View

17.

Ngakou Mukam J, Mvongo C, Nkoubat S, Fankem G, Mfopa A, Noubissi P . Early-induced diabetic obese rat MACAPOS 2. BMC Endocr Disord. 2023; 23(1):64. PMC: 10026472. DOI: 10.1186/s12902-022-01252-8. View

18.

Goto T, Lee J, Teraminami A, Kim Y, Hirai S, Uemura T . Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J Lipid Res. 2011; 52(5):873-84. PMC: 3073464. DOI: 10.1194/jlr.M011320. View

19.

Miranda J, Eseberri I, Lasa A, Portillo M . Lipid metabolism in adipose tissue and liver from diet-induced obese rats: a comparison between Wistar and Sprague-Dawley strains. J Physiol Biochem. 2018; 74(4):655-666. DOI: 10.1007/s13105-018-0654-9. View

20.

Marques C, Meireles M, Norberto S, Leite J, Freitas J, Pestana D . High-fat diet-induced obesity Rat model: a comparison between Wistar and Sprague-Dawley Rat. Adipocyte. 2016; 5(1):11-21. PMC: 4836488. DOI: 10.1080/21623945.2015.1061723. View